Cov-MS2 peptide standard
Peptide standard for mass spectrometry detection and absolute quantification of SARS-CoV-2, Influenza A/B and RSV, co-developed by PolyQuant and the University of Ghent.
|Order Number||Product description|
|PQ-CS-3500||SARS-CoV-2, Influenza, RSV MS Standard, 15N-labeled, complete protein|
|PQ-CS-3510||SARS-CoV-2, Influenza, RSV MS Standard, 15N-labeled, peptide mix|
|PQ-CS-3520||SARS-CoV-2, Influenza, RSV MS Standard, unlabeled, complete protein|
|PQ-CS-3530||SARS-CoV-2, Influenza, RSV MS Standard, unlabeled, peptide mix|
To place your order, please contact us directly through:
Phone: +49 (0)9405 96999 10
Or Fax: +49 (0)9405 96999 28
PolyQuant’s PQ-Cov-MS-2 peptide standard facilitates diagnosis of common respiratory infections in gargle solution or nasopharyngeal swabs with high accuracy and sensitivity through mass spectrometry.
The PQ-Cov-MS-2 peptide standard is based on PolyQuant’s proprietary QconCAT technology, providing 59 peptides as unlabelled or as heavy isotope labelled artificial protein to be released by protease treatment with trypsin during sample preparation.
PQ-Cov-MS-2 protein information
The 76.67 kDa synthetic protein comprises peptides for the SARS-CoV-2 nuclear capsid protein (NCAP), Influenza A and B NCAP and matrix protein (MP) and the human respiratory syncytial virus A MP and phosphoprotein (PP). Additionally, the synthetic protein comprises synthetic peptides for workflow calibration and standardisation (complementing product: RePLiCal, PQ-CS-1561).
Our prices are net prices, i.e. they do not contain value added taxes or customs fees. These taxes have to be paid by the customer.
Our products are usually shipped 1-2 business days after receiving the order.
Delivery costs depend on destination and packaging (either on dry ice or ambient temperature shipping).
For questions please contact us.